Search Results

Corporate Score 35 Neutral

Cigna Names Brian Evanko as Incoming CEO, Effective May 2026

Mar 04, 2026 11:00 UTC
CI, XLV, DJIA

Cigna Corporation has announced the appointment of Brian Evanko as its next Chief Executive Officer, succeeding David Cordani, who will retire in May 2026. The transition marks a planned leadership shift within the healthcare services giant.

  • Brian Evanko to become CEO of Cigna effective May 1, 2026
  • David Cordani to retire after serving as CEO since 2018
  • Cigna’s market cap: ~$245 billion; revenue: $79.8B (2025), net income: $4.3B
  • CI stock is part of the S&P 500 Health Care sector (XLV) and DJIA
  • Leadership transition is part of a pre-announced succession plan
  • No strategic or financial changes were announced with the appointment

Cigna Corporation has formally appointed Brian Evanko as its next Chief Executive Officer, effective May 1, 2026. Evanko, currently serving as Executive Vice President and Chief Operating Officer, will assume the top role following the retirement of David Cordani, who has led the company since 2018. The announcement underscores Cigna’s emphasis on internal leadership development, with Evanko having held key operational and strategic roles within the organization since 2015. The leadership change is part of a pre-announced succession plan and does not signal any immediate strategic or financial shift for the company. Cigna’s current market capitalization stands at approximately $245 billion, with its stock (CI) trading within the S&P 500 Health Care sector (XLV), which is a component of the Dow Jones Industrial Average (DJIA). The company reported revenue of $79.8 billion in fiscal year 2025, with net income of $4.3 billion, reflecting continued stability in its managed care and insurance operations. The transition is expected to proceed without disruption to ongoing operations. Evanko’s leadership experience spans clinical operations, member services, and digital health innovation, areas Cigna has prioritized in recent years. As the company expands its integrated care model and invests in data-driven health solutions, the appointment positions Evanko to guide the next phase of growth. Market reaction to the announcement was muted, with CI stock showing minimal movement in pre-market trading. The broader healthcare sector (XLV) and DJIA remained largely unchanged, indicating that investors view the leadership change as a routine corporate governance event. No material changes in guidance or capital allocation were disclosed.

The information presented is derived from publicly available corporate disclosures and does not reference or rely on proprietary data sources or third-party publishers.
Dashboard AI Chat Analysis Charts Profile